Biodimension Technology successfully closes ₹1.21 crore funding round.
Biodimension Technology Private Limited, a pioneering deep tech startup specializing in human tissue and organ development, has successfully raised ₹1.21 crore in its latest funding round. This investment will be instrumental in enhancing the company’s cleanroom facilities, accelerating product development, and boosting marketing efforts aimed at increasing the adoption of its innovative tissue models.
This funding marks a significant step for Biodimension as it aims to strengthen its leadership in the burgeoning non-animal testing market, setting the stage for sustainable growth within the pharmaceutical and cosmetic sectors.
Founded in 2021 and incubated by prominent institutions, Biodimension Technology focuses on creating functional replicas of human tissues using state-of-the-art biofabrication technologies. These advances provide a critical platform for drug, chemical, and cosmetic testing, toward a more ethical and accurate approach to research.
In response to the funding, the CEO emphasized, “With this financial backing, we are poised to scale our operations and extend the reach of our human tissue models. Our mission is to equip the pharmaceutical and cosmetic industries with advanced testing platforms that deliver more accurate, human-relevant data.”
A representative from the investment firm highlighted, “Biodimension’s innovative biofabrication approach aligns with our commitment to supporting transformative deep tech startups. Their human tissue models present a sustainable alternative to animal testing while significantly improving the accuracy of pharmaceutical research and product testing.”
Published – October 16, 2024 04:10 pm IST
